NLRP3 INHIBITOREN

Patent europeic · EP4337652 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4337652
Numer da la dumonda
EP22728228
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-05-2022
Publitgà
20-03-2024
Concedì
09-04-2025
La protecziun finescha il pli tard
09-05-2042
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
C07D 405/14 (2006.01)
C07D 471/08 (2006.01)
A61P 11/06 (2006.01)
A61K 31/53 (2006.01)
Prioritad
EP 21173452 12.05.2021
EP 21209447 22.11.2021
EP 21215859 20.12.2021
Dumonda PCT
PCT/EP2022/062525 10.05.2022
Publicaziun PCT
WO2022/238347 17.11.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 18-02-2026

    Midada

    Published in Swissreg on 18.02.2026

  3. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  4. 09-04-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 09.04.2025

Partidas

Possessur

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventur

BOUCHE, Lea Aurelie

4070 Basel

GUBA, Wolfgang

4070 Basel

JAESCHKE, Georg

4070 Basel

MESCH, Stefanie Katharina

4070 Basel

TOSSTORFF, Andreas Michael

4070 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.